Search

Author/Creator Hofman, Florence M

1. NEO100 enables brain delivery of blood‒brain barrier impermeable therapeutics. Issue 1 (2nd September 2020)

Authors:
Wang, Weijun; Marín-Ramos, Nagore I; He, Haiping; Zeng, Shan; Cho, Hee-Yeon; Swenson, Stephen D; Zheng, Long; Epstein, Alan L; Schönthal, Axel H; Hofman, Florence M; Chen, Ligang; Chen, Thomas C
Journal:
Neuro-oncology
Issue:
Volume 23:Issue 1(2021)
Page Start:
63
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pharmacokinetic properties of the temozolomide perillyl alcohol conjugate (NEO212) in mice. Issue 1 (20th November 2020)

Authors:
Cho, Hee-Yeon; Swenson, Steve; Thein, Thu Zan; Wang, Weijun; Wijeratne, Neloni R; Marín-Ramos, Nagore I; Katz, Jonathan E; Hofman, Florence M; Schönthal, Axel H; Chen, Thomas C
Journal:
Neuro-oncology advances
Issue:
Volume 2:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts. (29th August 2018)

Authors:
Bota, Daniela A; Chung, Jinah; Dandekar, Manisha; Carrillo, Jose A; Kong, Xiao-Tang; Fu, Beverly D; Hsu, Frank PK; Schönthal, Axel H; Hofman, Florence M; Chen, Thomas C; Zidovetzki, Raphael; Pretto, Chrystel; Strik, Ankie; Schijns, Virgil EJC; Stathopoulos, Apostolos
Journal:
CNS oncology
Issue:
Volume 7:Number 3(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗